Bioregulator Evidence Index

Data retrieved from PubMed on 2026-10-06. 41 compounds. Original dataset by The Bioregulator Atlas.

The short answer

Of 41 peptide bioregulators we track, 21 have at least one PubMed record under their own name, and only 10 have a record indexed as a human clinical trial (69 trial records out of 896 records in total). 20 have no PubMed record at all, including 18 brand-name natural (Cytomax) capsule products. Most of the human research that does exist was done on injectable preparations by Russian research groups.

Key findings

  • The most-published compounds are Thymalin (245 records), Cortexin (207 records), Epitalon (145 records). Thymalin and Cortexin are registered injectable medicines in Russia, which is where most of their trial records come from.
  • Epitalon has 145 PubMed records but 1 indexed as a human clinical trial. Most Epitalon work is cell and animal research.
  • Pinealon, the compound behind the 2026 sleep-podcast interest, has 18 PubMed records and 1 indexed human clinical trial.
  • Brand-name capsules such as Vladonix, Endoluten and Cerluten return zero PubMed records under their own names. Research quoted for them was done on related extracts, which is not the same as evidence for the capsule.
  • A count measures how much has been published, not whether a compound works or is safe.

The index

Download CSV
PubMed records and human clinical-trial records per bioregulator
CompoundTypeTargetPubMed recordsHuman-indexedHuman trialsRCTsFirst recordFirst human trialLatest recordQuery
ThymalinCytomaxThymus245165121198119822024PubMed
CortexinCytomaxBrain2071423417198019942026PubMed
EpitalonCytogenPineal Gland1454710199320022026PubMed
EpithalaminCytomaxPineal Gland883876197719792025PubMed
VilonCytogenThymus622031199720052023PubMed
ProstatilenCytomaxProstate281852199119912026PubMed
RetinalaminCytomaxRetina252043200120062025PubMed
CardiogenCytogenHeart2012002006–2025PubMed
LivagenCytogenLiver1914002001–2023PubMed
PinealonCytogenBrain181010200820122026PubMed
VesugenCytogenBlood Vessels117002008–2021PubMed
BronchogenCytogenBronchi72002006–2017PubMed
PancragenCytogenPancreas73002006–2015PubMed
SigumirCytomaxCartilage3310201220122023PubMed
SamprostCytomaxBladder31002011–2025PubMed
ChitomurCytomaxBladder2111201320132013PubMed
TestagenCytogenTestes21002011–2025PubMed
CartalaxCytogenCartilage11002023–2023PubMed
ChelohartCytomaxHeart10002015–2015PubMed
ChonlutenCytogenLungs11002022–2022PubMed
CrystagenCytogenThymus10002014–2014PubMed
BonomarlotCytomaxBone Marrow0000–––PubMed
BonothyrkCytomaxParathyroid0000–––PubMed
CerlutenCytomaxBrain0000–––PubMed
EndolutenCytomaxPineal Gland0000–––PubMed
GlandokortCytomaxAdrenal Glands0000–––PubMed
GotratixCytomaxMuscle0000–––PubMed
LibidonCytomaxProstate0000–––PubMed
NormoftalCytogenEye0000–––PubMed
OvagenName collision: "Ovagen" is also a veterinary FSH product; query restricted to peptide/bioregulator context.CytogenLiver0000–––PubMed
PielotaxCytomaxKidneys0000–––PubMed
StamakortCytomaxStomach0000–––PubMed
SuprefortCytomaxPancreas0000–––PubMed
SvetinormCytomaxLiver0000–––PubMed
TaxorestCytomaxLungs0000–––PubMed
TestolutenCytomaxTestes0000–––PubMed
ThyreogenCytomaxThyroid0000–––PubMed
VentfortCytomaxBlood Vessels0000–––PubMed
VisolutenCytomaxEye0000–––PubMed
VladonixCytomaxThymus0000–––PubMed
ZhenolutenCytomaxOvaries0000–––PubMed

How the numbers were made

  1. For each compound we searched PubMed (NCBI E-utilities, esearch) for its name and common spellings in titles and abstracts. Where a well-defined amino-acid sequence name is widely used (for example Ala-Glu-Asp-Gly for Epitalon) it is included. The exact query for every row is linked in the table and included in the CSV.
  2. Human-indexed adds the MeSH term Humans. Human trials adds: (humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt] OR controlled clinical trial[pt] OR clinical study[pt])). RCTs uses the Randomized Controlled Trial publication type alone.
  3. First record is the earliest publication year among matching records that also match (peptid*[tiab] OR polypeptid*[tiab] OR bioregulat*[tiab] OR Khavinson V[au] OR Khavinson VKh[au]), which removes older papers where the same word means something else.
  4. Duplicate spellings are merged (Kartalax into Cartalax, Honluten into Chonluten). Multi-ingredient complexes are not included.

Limits

  • PubMed indexes only part of the Russian-language literature, so these counts understate the total published record. They do reflect what most English-language readers, clinicians and AI search tools can find.
  • Publication-type tags are often missing on older papers, so some human studies are not counted as trials, and a tagged trial can still be small or uncontrolled.
  • A name match is not a study of the product sold under that name. Most human records concern injectable extracts, not oral capsules.
  • Name collisions are possible; known ones are noted in the table.

Use and citation

The data are free to reuse with a link to this page. Cite as: The Bioregulator Atlas, β€œBioregulator Evidence Index” (2026-10-06), https://www.thebioregulatoratlas.com/evidence-index.

For what each study actually found, open the compound's page or the study library. For background, read what bioregulators are.

Educational information only, not medical advice. Statements about dietary supplements have not been evaluated by the FDA. This site earns affiliate commissions on some product pages; this data page contains no product links.

HomeLibraryResearchFavoritesToolsVisuals